All News
In Memoriam: Christina Chung-Lun Wang
In Memoriam: Christina Chung-Lun Wang, MD (1944-2026)
It is with profound sadness and a heavy heart that we announce the passing of Prof. Christina Wang, a world-renowned leader and outstanding scientist in the field of Andrology and Reproductive Medicine.
Born in Nanjing, China, Prof. Wang received her medical degree from the University of Hong Kong and completed her postgraduate training in internal medicine and endocrinology in Hong Kong and Australia. In 1989, she moved to Los Angeles, and in 1993 she joined Harbor-UCLA Medical Center, where she spent more than three decades as a distinguished faculty member and leader.
During her remarkable career, Prof. Wang authored more than 350 peer-reviewed publications and over 70 book chapters and review articles. She served the World Health Organization for many years, including as Chair of the WHO Task Force on Methods for the Regulation of Male Fertility (1991–2002), and as a member of the editorial group responsible for the WHO Laboratory Manual for the Examination and Processing of Human Semen from 1980 to 2021.
Prof. Wang was deeply connected with the EAA and was one of the leaders of the Center for Men’s Health (Harbor-UCLA Male Reproductive Research Center), an EAA-accredited training center in the United States.
In 2023, she was appointed as one of the lead authors of the first guidelines on male contraception. Together with several distinguished colleagues, she made an outstanding contribution to coordinating the work that was ultimately published in Andrology in 2024 on behalf of the EAA and ASA (DOI: 10.1111/Andr.13525).
Alongside her unquestionable scientific achievements, Prof. Wang dedicated a significant part of her life to identifying, encouraging, and mentoring young andrologists from around the world. One notable example was in 2013, when, as President of the International Society of Andrology (ISA), she presented the ISA Young Andrologist Award during the 10th International Congress of Andrology to several individuals who have since become internationally recognized leaders in the field.
Prof. Wang remained actively involved in research and clinical science until the very end of her life. Most recently, she coordinated a double-blind, placebo-controlled clinical trial on hormonal male contraception, generating findings of great importance to the scientific community. She had been looking forward to presenting the preliminary results of this study at the upcoming European Congress of Andrology in Modena.
The entire EAA Board and the wider andrology community express their heartfelt condolences to Prof. Wang’s family, friends, collaborators, trainees, and colleagues around the world.
Prof. Wang’s example, scientific achievements, and lasting contributions to the field have left an indelible mark on our community. We are confident that her legacy will continue to inspire generations of scientists and clinicians in the years to come.
EAA Clinical Guidelines
IMPORTANT RESOURCE for ANDROLOGISTS!The EAA has published several state-of-the-art clinical guidelines to help ensure the best quality management in andrology, including the latest EAA-ASA Guidelines in Male Contraception. Find all guidelines here: https://andrologyacademy.net/eaa-clinical-guidelines
Recommended literature
Nieschlag et al Andrology textbook:
https://link.springer.com/book/10.1007/978-3-540-78355-8
EAA Guidelines:
https://www.andrologyacademy.net/eaa-clinical-guidelines
- EAA/EMQN best practice guidelines 2023
- Gynaecomastia: evaluation and management
- Management of bone health in the andrological outpatient clinic
- Management of oligo-asthenoteratozoospermia
- European academy of andrology guidelines on Klinefelter Syndrome Endorsing Organization: European Society of Endocrinology
- European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology
Profiles of the EAA Centers and Publications 2017-2022:
https://onlinelibrary.wiley.com/toc/20472927/2022/10/S2
Further articles
- Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
https://doi.org/10.1210/jc.2017-01658 - Testing for genetic contributions to infertility: potential clinical impact
https://doi.org/10.1080/14737159.2018.1453358 - Genetics of male infertility
https://doi.org/10.1038/s41585-018-0003-3 - Concepts in diagnosis and therapy for male reproductive impairment
http://dx.doi.org/10.1016/S2213-8587(16)30043-2 - Novel concepts in the aetiology of male reproductive impairment
http://dx.doi.org/10.1016/S2213-8587(16)30040-7 - Testicular microlithiasis and carcinoma in situ overview and proposed clinical guideline
https://doi.org/10.1111/j.1365-2605.2008.00937.x - Ultrasound of the male genital tract in relation to male reproductive health
-
Fode M, Ohl DA, Sønksen J.: A step-wise approach to sperm retrieval in men with neurogenic anejaculation.
Nat Rev Urol. 2015 Nov;12(11):607-16.
https://doi.org/10.1038/nrurol.2015.241 -
Nacchia A, Franco A, Cicione A, Riolo S, Santoro G, Romagnoli M, Sarcinelli L, Fiasconaro D, Ghezzo N, Gallo G, Tema G, Pastore AL, Salhi YA, Fuschi A, Carbone A, Franco G, Lombardo R, Tubaro A, De Nunzio C.: Medications Mostly Associated With Ejaculatory Disorders: Assessment of the Eudra-Vigilance and Food and Drug Administration Pharmacovigilance Databases Entries.
Urology. 2024 Mar;185:59-64.
https://doi.org/10.1016/j.urology.2023.12.021 -
Álvarez EV, García NZ, Gutiérrez Romero JM, Díaz-Fierros PR, Lozano Arana MD, Pérez TR, Álvarez JS, Rodríguez GB, Bernardo VC, Moyano Gallego MJ.: Sperm recovery from urine in men with retrograde ejaculation.
Adv Lab Med. 2024 Aug 22;5(4):356-365.
https://doi.org/10.1515/almed-2024-0109 -
Tony Chen, Evan A. Mulloy, Michael L. Eisenberg: Medical Treatment of Disorders of Ejaculation.
Urologic Clinics of North America, Volume 49, Issue 2, 2022, Pages 219-230,
https://doi.org/10.1016/j.ucl.2021.12.001
REACH petition
EAA has supported the ESE petition (https://www.ese-hormones.org/media/5028/reach-petition-14march2023.pdf) to the EU Commission for the immediate publication of the delayed REACH revision (scheduled for 2022). Delaying the REACH revision will keep a high level of exposure to endocrine-disrupting chemicals (EDCs), leading to severe health consequences.
EAA-endorsed Course in Andrological Endocrinology, 7-9 June 2023, Copenhagen, Denmark
EAA-endorsed Course in Andrological Endocrinology, 7-9 June 2023, Copenhagen, Denmark
Special benefits: 5 credits towards EAA Clinical Andrologist certification, and low fees for EAA members.
Invitation to BEED-ED Survey
EAA Center in Leuven, Belgium aims to map current clinical practices on methods to measure testosterone and SHGB in andrology centres in Europe. If you wish to participate, please click here.
ECA2024 Call for Bids
The call for hosting the 13th European Congress of Andrology (ECA 2024) is now open to national societies or academic groups established in the field of andrology. The biennial Congress usually attracts 400 to 500 attendees, lasts for 3 days, and comprises plenary lecturers, several parallel symposia and poster sessions.
Deadline for submission of Bids is 15 February 2023.
Please send your application with a preliminary budget to the EAA Office at
New ANDRONET-EAA Training School in Basic Semen Analysis
New ANDRONET-EAA Training School in Basic Semen Analysis will take place in Stockholm, 19-23 September 2022